Evidence map›Paper›PMID 23913689›Full record

ArticleThe Journal of biological chemistry2013

Characterization of a serine hydrolase targeted by acyl-protein thioesterase inhibitors in Toxoplasma gondii.

Louise E Kemp, Marion Rusch, Alexander Adibekian, Hayley E Bullen, Arnault Graindorge, Céline Freymond, Matthias Rottmann, Catherine Braun-Breton, Stefan Baumeister, Arthur T Porfetye and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Pathogens (Basel, Switzerland) · 2022
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. ThemSphere · 2018
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Louise E KempDepartment of Microbiology and Molecular Medicine, University Medical Center (CMU), University of Geneva, Rue Michel-Servet 1, CH-1211 Geneva, Switzerland.
Marion RuschDepartments of Chemical Biology.
Alexander AdibekianDepartment of Biochemistry, Sciences II, University of Geneva, Quai Ernest Ansermet 30, CH-1211 Geneva, Switzerland.
Hayley E BullenDepartment of Microbiology and Molecular Medicine, University Medical Center (CMU), University of Geneva, Rue Michel-Servet 1, CH-1211 Geneva, Switzerland.
Arnault GraindorgeDepartment of Microbiology and Molecular Medicine, University Medical Center (CMU), University of Geneva, Rue Michel-Servet 1, CH-1211 Geneva, Switzerland.
Céline FreymondDepartment of Parasite Chemotherapy, Swiss Tropical and Public Health Institute, Socinstrasse 57, P. O. Box, CH-4002 Basel, Switzerland; University of Basel, CH-4003 Basel, Switzerland.
Matthias RottmannDepartment of Parasite Chemotherapy, Swiss Tropical and Public Health Institute, Socinstrasse 57, P. O. Box, CH-4002 Basel, Switzerland; University of Basel, CH-4003 Basel, Switzerland.
Catherine Braun-BretonUniversity Montpellier II, CNRS UMR 5235, Montpellier, France.
Stefan BaumeisterDepartments of Mechanistic Cell Biology, Max Planck Institute of Molecular Physiology, Otto-Hahn-Strasse 11, 44227 Dortmund, Germany.
Arthur T PorfetyeDepartments of Mechanistic Cell Biology, Max Planck Institute of Molecular Physiology, Otto-Hahn-Strasse 11, 44227 Dortmund, Germany.
Ingrid R VetterDepartments of Mechanistic Cell Biology, Max Planck Institute of Molecular Physiology, Otto-Hahn-Strasse 11, 44227 Dortmund, Germany.
Christian HedbergDepartments of Chemical Biology.
Dominique Soldati-FavreDepartment of Microbiology and Molecular Medicine, University Medical Center (CMU), University of Geneva, Rue Michel-Servet 1, CH-1211 Geneva, Switzerland. Electronic address: dominique.soldati-favre@unige.ch.
University of Geneva · CHMax Planck Institute of Molecular Physiology · DECentre National de la Recherche Scientifique · FRMax Planck Society · DESwiss Tropical and Public Health Institute · CHUniversity of Basel · CH

Funding

Howard Hughes Medical Institute
6 · The paper itself

Abstract

In eukaryotic organisms, cysteine palmitoylation is an important reversible modification that impacts protein targeting, folding, stability, and interactions with partners. Evidence suggests that protein palmitoylation contributes to key biological processes in Apicomplexa with the recent palmitome of the malaria parasite Plasmodium falciparum reporting over 400 substrates that are modified with palmitate by a broad range of protein S-acyl transferases. Dynamic palmitoylation cycles require the action of an acyl-protein thioesterase (APT) that cleaves palmitate from substrates and conveys reversibility to this posttranslational modification. In this work, we identified candidates for APT activity in Toxoplasma gondii. Treatment of parasites with low micromolar concentrations of β-lactone- or triazole urea-based inhibitors that target human APT1 showed varied detrimental effects at multiple steps of the parasite lytic cycle. The use of an activity-based probe in combination with these inhibitors revealed the existence of several serine hydrolases that are targeted by APT1 inhibitors. The active serine hydrolase, TgASH1, identified as the homologue closest to human APT1 and APT2, was characterized further. Biochemical analysis of TgASH1 indicated that this enzyme cleaves substrates with a specificity similar to APTs, and homology modeling points toward an APT-like enzyme. TgASH1 is dispensable for parasite survival, which indicates that the severe effects observed with the β-lactone inhibitors are caused by the inhibition of non-TgASH1 targets. Other ASH candidates for APT activity were functionally characterized, and one of them was found to be resistant to gene disruption due to the potential essential nature of the protein.

Indexed as

Amino Acid SequenceEnzyme InhibitorsHumansLactonesModels, MolecularMolecular Sequence DataProtozoan ProteinsStructural Homology, ProteinThiolester HydrolasesToxoplasmaToxoplasmosisEnzyme InhibitorsLactonesLYPLA1 protein, humanLYPLA2 protein, humanProtozoan ProteinsThiolester HydrolasesAcyl-protein ThioesteraseEnzyme InhibitorsHydrolasesInhibitorParasitologyPlasmodium falciparumPosttranslational ModificationProtein PalmitoylationSerine HydrolaseToxoplasma gondii

Identifiers

PMID23913689
PMCPMC3779702
OpenAlexW2071327722

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.